Associate Professor, Neurology, University of Washington School of Medicine
Neurology
Dr. Cyrus P. Zabetian, MD
|
|
Give Review
Cyrus Zabetian practices Neurology. He attended University of Miami Miller School of Medicine. University of Miami Miller School of Medicine is ranked 45/0 in Research/PrimaryCare. Cyrus P. Zabetian, MD is a published MD. He has 101 papers published. The most current publication "[3H]-(+)-pentazocine binding to sigma recognition sites in human cerebellum."
Publications
- Precision Medicine: Clarity for the Complexity of Dementia.
- Screening of cognitive impairment in patients with Parkinson's Disease: diagnostic validity of the Brazilian versions of the Montreal Cognitive Assessment and the Adde...
- Cerebrospinal fluid peptides as potential Parkinson Disease biomarkers: a staged pipeline for discovery and validation.
- Cerebrospinal fluid Aβ42 levels and APP processing pathway genes in Parkinson's Disease.
- Cognitive profile of LRRK2-related Parkinson's Disease.
- A Peruvian family with a novel PARK2 mutation: Clinical and pathological characteristics.
- Glutamate Receptor Gene GRIN2A, Coffee, and Parkinson Disease.
- APOE, MAPT, and SNCA Genes and Cognitive Performance in Parkinson Disease.
- Lower plasma Apolipoprotein A1 levels are found in Parkinson's Disease and associate with apolipoprotein A1 genotype.
- Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's Disease.
- Targeted Discovery and Validation of Plasma Biomarkers of Parkinson's Disease.
- Evaluation of mild cognitive impairment subtypes in Parkinson's Disease.
- A genetic basis for the variable effect of smoking/nicotine on Parkinson's Disease.
- Mosaicism of alpha-synuclein gene rearrangements: Report of two unrelated cases of early-onset parkinsonism.
- Association mapping of the PARK10 region for Parkinson's Disease susceptibility genes.
- Association of Parkinson Disease with Structural and Regulatory Variants in the HLA Region.
- Cheek cell-derived α-synuclein and DJ-1 do not differentiate Parkinson's Disease from control.
- Memory, Mood, and Vitamin D in Persons with Parkinson's Disease.
- Clinical and Biochemical Differences in Patients Having Parkinson Disease With vs Without GBA Mutations.
- Altered splicing of ATP6AP2 causes X-linked parkinsonism with spasticity (XPDS).
- Plasma apolipoprotein A1 as a biomarker for parkinson's Disease.
- Novel Lrrk2-p.S1761R Mutation Is Not a Common Cause of Parkinson's Disease in Spain.
- DJ-1 isoforms in whole blood as potential biomarkers of Parkinson Disease.
- Risk prediction for complex Diseases: application to Parkinson Disease.
- Neuropsychologic assessment in collaborative Parkinson's Disease research: A proposal from the National Institute of Neurological Disorders and Stroke Morris K. Udall ...
- Common variation in the LRRK2 gene is a risk factor for Parkinson's Disease.
- GBA mutations increase risk for Lewy body Disease with and without Alzheimer Disease pathology.
- DJ-1 and ?SYN in LRRK2 CSF do not correlate with striatal dopaminergic function.
- Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's Disease modifier gene via interaction with coffee.
- Disease-related and genetic correlates of psychotic symptoms in Parkinson's Disease.
- Lrrk2 p.Q1111H substitution and Parkinson's Disease in Latin America.
- Replication of MAPT and SNCA, but not PARK16-18, as susceptibility genes for Parkinson's Disease.
- Complement 3 and factor h in human cerebrospinal fluid in Parkinson's Disease, Alzheimer's Disease, and multiple-system atrophy.
- Cerebrospinal fluid biomarkers for Parkinson Disease diagnosis and progression.
- Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's Disease.
- The UCHL1 S18Y polymorphism and Parkinson's Disease in a Japanese population.
- Evidence for More than One Parkinson's Disease-Associated Variant within the HLA Region.
- The genetics of Parkinson Disease.
- CSF Aβ(42) and tau in Parkinson's Disease with cognitive impairment.
- SNCA variant associated with Parkinson Disease and plasma alpha-synuclein level.
- Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's Disease.
- A novel X-linked four-repeat tauopathy with Parkinsonism and spasticity.
- Glycoproteomics in neurodegenerative Diseases.
- Visualizing Disease associations: graphic analysis of frequency distributions as a function of age using moving average plots (MAP) with application to Alzheimer's and...
- Ashkenazi Parkinson's Disease patients with the LRRK2 G2019S mutation share a common founder dating from the second to fifth centuries.
- Lrrk2 R1441G-related Parkinson's Disease: evidence of a common founding event in the seventh century in Northern Spain.
- LRRK2 mutations and risk variants in Japanese patients with Parkinson's Disease.
- Genetic polymorphism at codon 129 of the prion protein gene is not associated with multiple sclerosis.
- Genetic association between alpha-synuclein and idiopathic Parkinson's Disease.
- Glucocerebrosidase gene mutations: a risk factor for Lewy body Disorders.
- Combined effects of smoking, coffee, and NSAIDs on Parkinson's Disease risk.
- Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's Disease.
- DBH -1021C-->T does not modify risk or age at onset in Parkinson's Disease.
- Heterozygous parkin point mutations are as common in control subjects as in Parkinson's patients.
- A single nucleotide polymorphism at DBH, possibly associated with attention-deficit/hyperactivity disorder, associates with lower plasma dopamine beta-hydroxylase acti...
- LRRK2 G2019S in families with Parkinson Disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia ago.
- Clinical features of Parkinson Disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations.
- Parkinson's Disease and LRRK2: frequency of a common mutation in U.S. movement disorder clinics.
- Analysis of the LRRK2 G2019S mutation in Alzheimer Disease.
- Validity and utility of a LRRK2 G2019S mutation test for the diagnosis of Parkinson's Disease.
- Haplotype-controlled analysis of the association of a non-synonymous single nucleotide polymorphism at DBH (+ 1603C --> T) with plasma dopamine beta-hydroxylase activity.
- Escaping Parkinson's Disease: a neurologically healthy octogenarian with the LRRK2 G2019S mutation.
- Regulation of drug reward by cAMP response element-binding protein: evidence for two functionally distinct subregions of the ventral tegmental area.
- A revised allele frequency estimate and haplotype analysis of the DBH deficiency mutation IVS1+2T --> C in African- and European-Americans.
- Variations in the dopamine beta-hydroxylase gene are not associated with the autonomic Disorders, pure autonomic failure, or multiple system atrophy.
- The structure of linkage disequilibrium at the DBH locus strongly influences the magnitude of association between diallelic markers and plasma dopamine beta-hydroxylas...
- A genotype-controlled analysis of plasma dopamine beta-hydroxylase in healthy and alcoholic subjects: evidence for alcohol-related differences in noradrenergic function.
- Mutations in the dopamine beta-hydroxylase gene are associated with human norepinephrine deficiency.
- Genotype-controlled analysis of plasma dopamine beta-hydroxylase activity in psychotic unipolar major depression.
- Identification of a novel Parkinson's Disease locus via stratified genome-wide association study.
- Pacific northwest udall center of excellence clinical consortium: study design and baseline cohort characteristics.
- A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus.
- Functional variants at CYP2A6: new genotyping methods, population genetics, and relevance to studies of tobacco dependence.
- [3H]-(+)-pentazocine binding to sigma recognition sites in human cerebellum.
- Effects of environmental salinity on pituitary growth hormone content and cell activity in the euryhaline tilapia, Oreochromis mossambicus.
- Sigma receptors are associated with cortical limbic areas in the primate brain.
- Human genetics of plasma dopamine beta-hydroxylase activity: applications to research in psychiatry and neurology.
- A clinic-based study of the LRRK2 gene in Parkinson Disease yields new mutations.
- Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative Disorders.
- Identification and haplotype analysis of LRRK2 G2019S in Japanese patients with Parkinson Disease.
- Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson''s Disease: a large-scale international study.
- Exploring gene-environment interactions in Parkinson''s Disease.
- Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of...
- Lack of evidence for an association between UCHL1 S18Y and Parkinson''s Disease.
- Genotypic and haplotypic associations of the DBH gene with plasma dopamine beta-hydroxylase activity in African Americans.
- A novel progranulin mutation associated with variable clinical presentation and tau, TDP43 and alpha-synuclein pathology.
- Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson Disease.
- LRRK2 mutations in patients with Parkinson''s Disease from Peru and Uruguay.
- Haplotype analysis of Lrrk2 R1441H carriers with parkinsonism.
- Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson''s Disease: a case-control study.
- Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson''s Disease.
- Human PON1, a biomarker of risk of Disease and exposure.
- DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson''s Disease.
- Association between the ubiquitin carboxyl-terminal esterase L1 gene (UCHL1) S18Y variant and Parkinson's Disease: a HuGE review and meta-analysis.
- Multicenter analysis of glucocerebrosidase mutations in Parkinson's Disease.
- Cognitive impairment and dementia in patients with Parkinson Disease.
- An attempt to replicate interaction between coffee and CYP1A2 gene in connection to Parkinson''s Disease.
- Postural instability/gait disturbance in Parkinson''s Disease has distinct subtypes: an exploratory analysis.
- A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2.
- Phosphorylated α-synuclein in Parkinson's Disease.
Schools
University of Miami School of Medicine
University Wa
Yale University
Conditions Treated
- Alzheimer's Disease
- Brachial Plexus Palsy
- Carpal Tunnel Syndrome
- Dementia
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Education
-
Yale-New Haven Hospital -
University of Washington -
University of Miami Miller School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Seema Afridi, MD |
|
|
Dr. Kyra J. Becker, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Lynne P. Taylor, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christina V. Darby, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregg Meekins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Timothy A. Scearce, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joanna E. Wrede, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John W. Henson IV, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jenny Siv, MD
This Doctor is OpenDoctor Recommended.
|